1,25-dihydroxyvitamin D3 inhibits directly human osteoclastogenesis by down-regulation of the c-Fms and RANK expression

Joint Bone Spine

Volumn 80, Issue 3, 2013, Pages 307-314

  Kim, Tae Hwan ^a   Lee, Bitnara ^a   Kwon, Eunji ^a   Choi, Choong Hyeok ^a   Sung, Il Hoon ^a   Kim, Yongjin ^b   Sohn, Jeongwon ^b   Ji, Jong Dae ^b  

^a Hanyang University Hospital for Rheumatic Diseases   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

1,25 dihydroxyvitamin D3; C Fms; Osteoclast; RANK

Indexed keywords

C FMS PROTEIN; CALCITRIOL; CCAAT ENHANCER BINDING PROTEIN BETA; CELL SURFACE PROTEIN; PROTEIN C FOS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG; BONE DENSITY CONSERVATION AGENT; COLONY STIMULATING FACTOR RECEPTOR; TNFRSF11A PROTEIN, HUMAN;

ARTICLE; DOWN REGULATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; OSTEOCLAST; OSTEOCLASTOGENESIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; DRUG EFFECTS; GENETICS; HEMATOPOIETIC STEM CELL; METABOLISM; NORMAL HUMAN;

BONE DENSITY CONSERVATION AGENTS; CALCITRIOL; CCAAT-ENHANCER-BINDING PROTEIN-BETA; CELL DIFFERENTIATION; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION; HEALTHY VOLUNTEERS; HEMATOPOIETIC STEM CELLS; HUMANS; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR;

EID: 84878352012     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2012.09.011     Document Type: Article

References (27)

1. Takayanagi H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 2007, 7:292-304.
2. Teitelbaum S.L. Osteoclasts; culprits in inflammatory osteolysis. Arthritis Res Ther 2006, 8:201.
3. Walsh N.C., Crotti T.N., Goldring S.R., et al. Rheumatic diseases: the effects of inflammation on bone. Immunol Rev 2005, 208:228-251.
4. Schett G. Cells of the synovium in rheumatoid arthritis. Osteoclasts. Arthritis Res Ther 2007, 9:203.
5. Li P., Schwarz E.M., O'Keefe R.J., et al. RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis. J Bone Miner Res 2004, 19:207-213.
6. Pettit A.R., Ji H., von Stechow D., et al. TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis. Am J Pathol 2001, 159:1689-1699.
7. Redlich K., Hayer S., Ricci R., et al. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J Clin Invest 2002, 110:1419-1427.
8. Bouillon R., Carmeliet G., Verlinden L., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29:726-776.
9. Takahashi N., Yamana H., Yoshiki S., et al. Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 1988, 122:1373-1382.
10. Yasuda H., Shima N., Nakagawa N., et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci U S A 1998, 95:3597-3602.
11. Shiraishi A., Takeda S., Masaki T., et al. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen. J Bone Miner Res 2000, 15:770-779.
12. Uchiyama Y., Higuch I.Y., Takeda S., et al. ED-71, a vitamin D analog, is a more potent inhibitor of bone resorption than alfacalcidol in an estrogen-deficient rat model of osteoporosis. Bone 2002, 30:582-588.
13. Joffe I., Epstein S. Osteoporosis associated with rheumatoid arthritis: pathogenesis and management. Semin Arthritis Rheum 1991, 20:256-272.
14. Denis I., Cournot G., Lacroix H., et al. In vivo bone metabolism and ex vivo bone marrow osteoprogenitors in vitamin D-deprived pigs. Bone 2000, 26:491-498.
15. Shibata T., Shira-Ishi A., Sato T., et al. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow. J Bone Miner Res 2002, 17:622-629.
16. Sakai S., Takaishi H., Matsuzaki K., et al. 1-Alpha, 25-dihydroxy vitamin D3 inhibits osteoclastogenesis through IFN-beta-dependent NFATc1 suppression. J Bone Miner Metab 2009, 27:643-652.
17. Takasu H., Sugita A., Uchiyama Y., et al. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs. J Clin Invest 2006, 116:528-535.
18. Sorensen M.G., Henriksen K., Schaller S., et al. Characterization of osteoclasts derived from CD14+ monocytes isolated from peripheral blood. J Bone Miner Metab 2007, 25:36-45.
19. Smink J.J., Begay V., Schoenmaker T., et al. Transcription factor C/EBPbeta isoform ratio regulates osteoclastogenesis through MafB. EMBO J 2009, 28:1769-1781.
20. Lee B.N., Kim T.H., Jun J.B., et al. Upregulation of interleukin-1beta production by 1,25-Dihydroxyvitamin D(3) in activated human macrophages. Mol Biol Rep 2011, 38:2193-2201.
21. Arai F., Miyamoto T., Ohneda O., et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. J Exp Med 1999, 190:1741-1754.
22. Ji J.D., Park-Min K.H., Shen Z., et al. Inhibition of RANK expression and osteoclastogenesis by TLRs and IFN-{gamma} in human osteoclast precursors. J Immunol 2009, 183:7223-7233.
23. Lee B., Kim T.H., Jun J.B., et al. Direct inhibition of human RANK+ osteoclast precursors identifies a homeostatic function of IL-1beta. J Immunol 2010, 185:5926-5934.
24. Takayanagi H. Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 2005, 83:170-179.
25. Biskobing D.M., Fan D., Rubin J. c-fms mRNA is regulated posttranscriptionally by 1,25(OH)2D3 in HL-60 cells. Calcif Tissue Int 1997, 61:205-209.
26. Zhu K., Glaser R., Mrowietz U. Vitamin D(3) and analogues modulate the expression of CSF-1 and its receptor in human dendritic cells. Biochem Biophys Res Commun 2002, 297:1211-1217.
27. Kim K., Kim J.H., Lee J., et al. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 2007, 109:3253-3259.